Manufacturing

AIST Unveils New Fingerprinting Method for Biomanufacturing
Biotech & Bioprocessing AIST Unveils New Fingerprinting Method for Biomanufacturing

The National Institute of Advanced Industrial Science and Technology (AIST) has introduced a transformative analytical technique designed to redefine how manufacturers assess the quality and consistency of culture media. This innovation utilizes a sophisticated fingerprinting approach to capture

How Will PoLARIS Redefine Autonomous Material Science?
Tech & Innovation How Will PoLARIS Redefine Autonomous Material Science?

The traditional approach to developing soft materials like specialized polymers and healthcare-essential liquids has historically relied on manual, labor-intensive cycles that frequently stall progress for years at a time. To address these systemic bottlenecks, the University of Chicago and Argonne

A Revenue Flywheel Accelerates Molecular Nanotechnology
Management & Regulatory A Revenue Flywheel Accelerates Molecular Nanotechnology

The long-prophesied era of molecularly precise manufacturing has finally moved beyond the confines of theoretical physics and into the aggressive world of high-stakes capital investment, marking a shift from academic curiosity to industrial reality. This transition is being driven by a powerful

New Models Scale Personalized Rare Disease Therapies
Research & Development New Models Scale Personalized Rare Disease Therapies

The pharmaceutical landscape is undergoing a radical transformation as the era of blockbuster drugs for the masses gives way to a highly specialized approach designed for individuals with unique genetic mutations. This paradigm shift was catalyzed by the landmark case of Mila Makovec, who faced a

CellOrigin Advances Next-Gen Cell Therapy for Solid Tumors
Biotech & Bioprocessing CellOrigin Advances Next-Gen Cell Therapy for Solid Tumors

The current oncology landscape faces a persistent bottleneck as traditional chimeric antigen receptor T-cell therapies continue to struggle with the immunosuppressive defenses of solid tumors. While liquid cancers have seen remarkable recovery rates, the dense extracellular matrix and hostile

Is Ready-Made Cell Therapy the Future of Cancer Care?
Research & Development Is Ready-Made Cell Therapy the Future of Cancer Care?

Medical facilities currently face a significant bottleneck where patients with aggressive hematological malignancies must wait weeks for personalized cell manufacturing while their conditions deteriorate rapidly. The established autologous model requires extracting a patient's own T-cells,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later